227 related articles for article (PubMed ID: 30973610)
1. Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With "Good Prognosis" Rectal Cancer Eligible for Primary Surgery: The Phase 2 Nonrandomized QuickSilver Clinical Trial.
Kennedy ED; Simunovic M; Jhaveri K; Kirsch R; Brierley J; Drolet S; Brown C; Vos PM; Xiong W; MacLean T; Kanthan S; Stotland P; Raphael S; Chow G; O'Brien CA; Cho C; Streutker C; Wong R; Schmocker S; Liberman S; Reinhold C; Kopek N; Marcus V; Bouchard A; Lavoie C; Morin S; Périgny M; Wright A; Neumann K; Clarke S; Patil NG; Arnason T; Williams L; McLeod R; Brown G; Mathieson A; Pooni A; Baxter NN
JAMA Oncol; 2019 Jul; 5(7):961-966. PubMed ID: 30973610
[TBL] [Abstract][Full Text] [Related]
2. QuickSilver: A Phase II Study Using Magnetic Resonance Imaging Criteria to Identify "Good Prognosis" Rectal Cancer Patients Eligible for Primary Surgery.
;
JMIR Res Protoc; 2015 Apr; 4(2):e41. PubMed ID: 25871328
[TBL] [Abstract][Full Text] [Related]
3. Circumferential Resection Margin Status as a Predictive Factor for Recurrence in Preoperative MRI for Advanced Lower Rectal Cancer Without Preoperative Therapy.
Mazaki J; Tsukamoto S; Miyake M; Moritani K; Sakamoto R; Shida D; Kanemitsu Y
Dis Colon Rectum; 2021 Jan; 64(1):71-80. PubMed ID: 33306533
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation.
Chang GJ; You YN; Park IJ; Kaur H; Hu CY; Rodriguez-Bigas MA; Skibber JM; Ernst RD
Dis Colon Rectum; 2012 Apr; 55(4):371-7. PubMed ID: 22426259
[TBL] [Abstract][Full Text] [Related]
5. Correlation Between Endorectal Ultrasound and Magnetic Resonance Imaging for Predicting the Circumferential Resection Margin in Patients With Mid-Low Rectal Cancer Without Preoperative Chemoradiotherapy.
Ye D; Zhu Z; Chen F; Lie C; Li W; Lin Y; Qiu S
J Ultrasound Med; 2020 Mar; 39(3):569-577. PubMed ID: 31617244
[TBL] [Abstract][Full Text] [Related]
6. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
[TBL] [Abstract][Full Text] [Related]
7. Impact of Mucin Proportion in the Pretreatment MRI on the Outcomes of Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
Kim E; Kim K; Kim SH; Han SW; Kim TY; Jeong SY; Park KJ; Koh J; Kang GH; Chie EK
Cancer Res Treat; 2019 Jul; 51(3):1188-1197. PubMed ID: 30590006
[TBL] [Abstract][Full Text] [Related]
8. MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial.
Patel UB; Brown G; Machado I; Santos-Cores J; Pericay C; Ballesteros E; Salud A; Isabel-Gil M; Montagut C; Maurel J; Ramón-Ayuso J; Martin N; Estevan R; Fernandez-Martos C
Ann Oncol; 2017 Feb; 28(2):344-353. PubMed ID: 28426108
[TBL] [Abstract][Full Text] [Related]
9. Significance of MRI in rectal carcinoma therapy optimization - correlation of preoperative T- and N-staging with definitive histopathological findings.
Danihel L; Danihel L; Rajcok M; Mosna K; Belan V; Varga I; Schnorrer M
Neoplasma; 2019 May; 66(3):494-498. PubMed ID: 30793609
[TBL] [Abstract][Full Text] [Related]
10. Use of Preoperative MRI to Select Candidates for Local Excision of MRI-Staged T1 and T2 Rectal Cancer: Can MRI Select Patients With N0 Tumors?
An C; Huh H; Han KH; Kim MJ; Kim NK; Kim H; Lim JS
Dis Colon Rectum; 2015 Oct; 58(10):923-30. PubMed ID: 26347963
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of mesorectal fascia in mid and low anterior rectal cancer using endorectal ultrasound is feasible and reliable: a comparison with MRI findings.
Granero-Castro P; Muñoz E; Frasson M; García-Granero A; Esclapez P; Campos S; Flor-Lorente B; Garcia-Granero E
Dis Colon Rectum; 2014 Jun; 57(6):709-14. PubMed ID: 24807595
[TBL] [Abstract][Full Text] [Related]
12. Factors related to preoperative assessment of the circumferential resection margin and the extent of mesorectal invasion by magnetic resonance imaging in rectal cancer: a prospective comparison study.
Kim YW; Cha SW; Pyo J; Kim NK; Min BS; Kim MJ; Kim H
World J Surg; 2009 Sep; 33(9):1952-60. PubMed ID: 19603224
[TBL] [Abstract][Full Text] [Related]
13. Low- Versus High-Risk Rectal Cancer Based on MRI Features: Outcomes in Patients Treated Without Neoadjuvant Chemoradiotherapy.
Jia XX; Wang Y; Cheng J; Yao X; Yin MJ; Zhou J; Ye YJ
AJR Am J Roentgenol; 2018 Aug; 211(2):327-334. PubMed ID: 29927331
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the 2020 NICE criteria for preoperative radiotherapy in patients with rectal cancer treated by surgery alone in comparison with proven MRI prognostic factors: a retrospective cohort study.
Lord AC; Corr A; Chandramohan A; Hodges N; Pring E; Airo-Farulla C; Moran B; Jenkins JT; Di Fabio F; Brown G
Lancet Oncol; 2022 Jun; 23(6):793-801. PubMed ID: 35512720
[TBL] [Abstract][Full Text] [Related]
15. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study.
Taylor FG; Quirke P; Heald RJ; Moran BJ; Blomqvist L; Swift IR; Sebag-Montefiore D; Tekkis P; Brown G;
J Clin Oncol; 2014 Jan; 32(1):34-43. PubMed ID: 24276776
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging performed before and after preoperative chemoradiotherapy in rectal cancer: predictive factors of recurrence and prognostic significance of MR-detected extramural venous invasion.
Prampolini F; Taschini S; Pecchi A; Sani F; Spallanzani A; Gelsomino F; Kaleci S; Torricelli P
Abdom Radiol (NY); 2020 Oct; 45(10):2941-2949. PubMed ID: 30483843
[TBL] [Abstract][Full Text] [Related]
17. [Application of convolutional neural network to risk evaluation of positive circumferential resection margin of rectal cancer by magnetic resonance imaging].
Xu JH; Zhou XM; Ma JL; Liu SS; Zhang MS; Zheng XF; Zhang XY; Liu GW; Zhang XX; Lu Y; Wang DS
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jun; 23(6):572-577. PubMed ID: 32521977
[No Abstract] [Full Text] [Related]
18. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.
Ogura A; Konishi T; Beets GL; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Rutten HJT; Tuynman JB; Kusters M;
JAMA Surg; 2019 Sep; 154(9):e192172. PubMed ID: 31268504
[TBL] [Abstract][Full Text] [Related]
19. Phase II Trial of Neoadjuvant Chemotherapy, Chemoradiotherapy, and Laparoscopic Surgery with Selective Lateral Node Dissection for Poor-Risk Low Rectal Cancer.
Konishi T; Shinozaki E; Murofushi K; Taguchi S; Fukunaga Y; Nagayama S; Fujimoto Y; Akiyoshi T; Nagasaki T; Suenaga M; Chino A; Kawachi H; Yamamoto N; Ishikawa Y; Oguchi M; Ishizuka N; Ueno M; Yamaguchi K
Ann Surg Oncol; 2019 Aug; 26(8):2507-2513. PubMed ID: 30963400
[TBL] [Abstract][Full Text] [Related]
20. Selection of Patients With Rectal Cancer for Preoperative Chemoradiotherapy: Are T Category and Nodal Status All That Matters?
Pooni A; Al-Sukhni E; Milot L; Fruitman M; Victor JC; Schmocker S; Brown G; Kennedy E
Dis Colon Rectum; 2019 Apr; 62(4):447-453. PubMed ID: 30451758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
